1600-6143/asset/olbannerleft.gif?v=1&s=c46a3f174bfd9c6eb548cc809401524372c32e90)
1600-6143/asset/olbannerright.gif?v=1&s=9fc9790fa8ad5ef85aeaf408bf0d3d969d2fc012)
Editorial
You have free access to this content
Below the Waterline—The Danger of De Novo Donor-Specific HLA Antibodies
Article first published online: 26 APR 2012
DOI: 10.1111/j.1600-6143.2012.04016.x
© Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons
Additional Information
How to Cite
Kokko, K. E. and Colvin, R. B. (2012), Below the Waterline—The Danger of De Novo Donor-Specific HLA Antibodies. American Journal of Transplantation, 12: 1077–1078. doi: 10.1111/j.1600-6143.2012.04016.x
Publication History
- Issue published online: 26 APR 2012
- Article first published online: 26 APR 2012
- Received 18 January 2012, revised 18 January 2012, and accepted for publication 24 January 2012
- Abstract
- Article
- References
- Cited By
Keywords:
- Allocation;
- antibody mediated rejection;
- donor specific antibody;
- kidney transplantation
The authors describe the findings of Wiebe et al (page 1157) that de novo donor-specific HLA antibodies have adverse prognostic implications for long-term renal transplant survival and discuss how these findings may impact individual patient care and direct future research.